ADCIRCA

This brand name is authorized in Austria, Australia, Canada, Germany, Estonia, Spain, France, Croatia, Ireland, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, United Kingdom, United States

Active ingredients

The drug ADCIRCA contains one active pharmaceutical ingredient (API):

1 Tadalafil UNII 742SXX0ICT - TADALAFIL

Tadalafil is a selective, reversible inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). When sexual stimulation causes the local release of nitric oxide, inhibition of PDE5 by tadalafil produces increased levels of cGMP in the corpus cavernosum. This results in smooth muscle relaxation and inflow of blood into the penile tissues, thereby producing an erection. Tadalafil has no effect in the absence of sexual stimulation. Read about Tadalafil

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G04BE08	Tadalafil	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BE Drugs used in erectile dysfunction
Discover more medicines within G04BE08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 12150L, 12151M, 1304P, 1308W
Country: CA	Health Products and Food Branch	Identifier(s): 02338327
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 05908891, 05908916, 10536687
Country: EE	Ravimiamet	Identifier(s): 1460225, 1460236
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 08476006
Country: FR	Base de données publique des médicaments	Identifier(s): 63206355
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 182492
Country: IE	Health Products Regulatory Authority	Identifier(s): 88530
Country: IT	Agenzia del Farmaco	Identifier(s): 039598026
Country: JP	医薬品医療機器総合機構	Identifier(s): 2190030F1029
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1056532, 1056533
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 68241
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 15164
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100206193
Country: US	FDA, National Drug Code	Identifier(s): 43353-070, 66302-467